COVID-19: all 7,774 studies

Page 75 of 78. Open to participants first (482), then studies with results posted, then the rest; newest registration first within each.

• PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE CompoundsTerminatedNCT04351191Phase 4
• Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19Status unknownNCT04351152Phase 3
• Impact of the COVID-19 Pandemic in Gynecological OncologyCompletedNCT04351139
• Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19Status unknownNCT04350931Phase 3
• First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19CompletedNCT04350736Phase 1
• Awake Prone Position in Hypoxemic Patients With Coronavirus Disease 19 COVID-19 (COVI-PRONE)CompletedNCT04350723Not applicable
• Umifenovir in Hospitalized COVID-19 PatientsStatus unknownNCT04350684Phase 4
• Interferon Beta 1a in Hospitalized COVID-19 PatientsStatus unknownNCT04350671Phase 4
• Polyvalent Immunoglobulin in COVID-19 Related ARdsCompletedNCT04350580Phase 3
• COVID-19 Remote MonitoringWithdrawnNCT04350476Not applicable
• Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at MontefioreWithdrawnNCT04350450Phase 2
• Trial to Study the Benefit of Colchicine in Patients With COVID-19CompletedNCT04350320Phase 3
• Emotional Burden of Healthcare Professionals and Covid Infection 19CompletedNCT04350099
• Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 InfectionWithdrawnNCT04350086Phase 4
• Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID)CompletedNCT04350073
• ICU Trial in Critical Ill COVID-19 PatientsCompletedNCT04349982
• Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 PneumoniaCompletedNCT04349618Not applicable
• Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19CompletedNCT04349592Not applicable
• Role of Immune and Inflammatory Response in Recipients of Allogeneic Haematopoietic Stem Cell Transplantation (SCT) Affected by Severe COVID19Status unknownNCT04349540
• The Fleming [FMTVDM] Directed CoVid-19 Treatment ProtocolCompletedNCT04349410Phase 2/3
• Efficacy and Safety of Favipiravir in Management of COVID-19CompletedNCT04349241Phase 3
• Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health ProfessionalsWithdrawnNCT04349228Phase 3
• Beaumont Health Large-scale Automated Serologic Testing for COVID-19CompletedNCT04349202
• A COVID-19 Symptom, Exposure and Immune Response RegistryCompletedNCT04348942
• Birth Experience During COVID-19 ConfinementCompletedNCT04348929Not applicable
• Plasma Rich Antibodies From Recovered Patients From COVID19Status unknownNCT04348877Not applicable
• COVID-19 Diagnostic Self-testing Using Virtual Point-of-careStatus unknownNCT04348864Not applicable
• Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19.CompletedNCT04348695Phase 2
• Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 InfectionTerminatedNCT04348513Phase 2
• Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19SuspendedNCT04348474Early Phase 1
• Observational Study, Use of Canakinumab Administered Subcutaneously in the Treatment COVID-19 PneumoniaTerminatedNCT04348448
• Evaluating the Immune Response for COVID-19CompletedNCT04348422
• Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19CompletedNCT04348409Not applicable
• Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19.CompletedNCT04348383Phase 2
• Hydrocortisone for COVID-19 and Severe HypoxiaCompletedNCT04348305Phase 3
• Transmissibility and Viral Load of SARS-CoV-2 in Oral SecretionsCompletedNCT04348240
• Screening & Risk Assessment of Healthcare Workers & Infection Control in University & COVID-19 Quarantine HospitalsCompletedNCT04348214
• Safety and Efficacy of Ruxolitinib for COVID-19WithdrawnNCT04348071Phase 2/3
• Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19TerminatedNCT04347980Phase 3
• Respiratory and Hemodynamic Changes Induced in Mechanically Ventilated Patients for COVID-19CompletedNCT04347928
• The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19CompletedNCT04347915Phase 2
• Preventing COVID-19 in Healthcare Workers With HCQ: A RCTWithdrawnNCT04347889Phase 2
• Outcome of COVID-19 Cases Based on Tuberculin Test: Can Previous BCG Alter the Prognosis?Status unknownNCT04347876
• A Cohort of Patients With Possible or Confirmed SARS-CoV-2 (COVID-19)Status unknownNCT04347850
• Predict Adverse Events by Covid-19 NephritisCompletedNCT04347824
• IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORTCompletedNCT04347798
• Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19CompletedNCT04347681Phase 2
• EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRAWithdrawnNCT04347512Phase 3
• Honey & Nigella Sativa Trial Against COVID-19CompletedNCT04347382Phase 3
• A Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 DiseaseCompletedNCT04347369
• Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 RegistryStatus unknownNCT04347278
• A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 PatientsCompletedNCT04347174Not applicable
• Implementation of Physiotherapy on COVID-19 Patients in ICUStatus unknownNCT04347070
• Burnout Among Caregivers Facing COVID-19 Health Crisis at a Non-conventional Intensive Care Unit Compared to a Conventional Intensive Care UnitStatus unknownNCT04346810
• CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 CohortStatus unknownNCT04346797Phase 2
• Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE CompoundsTerminatedNCT04346667Phase 4
• Convalescent Antibodies Infusion in Critically Ill COVID 19 PatientsTerminatedNCT04346589Not applicable
• Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19)Status unknownNCT04346368Phase 1/2
• Efficacy of Early Administration of Tocilizumab in COVID-19 PatientsTerminatedNCT04346355Phase 2
• CoVid-19 - Infection and Antibody Formation in the Viennese PopulationCompletedNCT04346264
• Oropharyngeal Dysphagia in Patients With COVID-19CompletedNCT04346212
• Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19Status unknownNCT04346147Phase 2
• Retrospective Study on Severe Respiratory Illness to Access the Presence of COVID-19Status unknownNCT04346056
• To Access the Egyptian COVID-19 Whole Genome by NGS and Compare to the International Worldwide DatabaseStatus unknownNCT04346043
• Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response SyndromeCompletedNCT04346017Not applicable
• Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 CohortCompletedNCT04345991Phase 2
• Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial)TerminatedNCT04345861Phase 2/3
• A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized PatientsTerminatedNCT04345692Phase 3
• Anti COVID-19 Convalescent Plasma TherapyStatus unknownNCT04345679Early Phase 1
• Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University HospitalCompletedNCT04345536
• Convalescent Plasma Therapy vs. SOC for the Treatment of COVID-19 in Hospitalized PatientsCompletedNCT04345523Phase 2
• Testing for COVID-19 Infection in Asymptomatic PersonsCompletedNCT04345510
• Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of ProgressionStatus unknownNCT04345445Phase 3
• Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent.Status unknownNCT04345315
• Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 InfectionCompletedNCT04345276Phase 4
• Collection of Anti-SARS-CoV-2 Immune PlasmaCompletedNCT04344977
• Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical TrialTerminatedNCT04344951Phase 2
• Covid 19 Pandemic. Emerging Legal and Ehical Disputes Over Patient ConfidentialityStatus unknownNCT04344938
• Non Invasive Positive Pressure Ventilation to Minimize Aerosolization for COVID 19TerminatedNCT04344925
• Short and Long-term Psychological Impact of Covid-19 on The EgyptiansStatus unknownNCT04344834
• Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin®/Zeribev®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 CohortStatus unknownNCT04344782Phase 2
• Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 CohortStatus unknownNCT04344756Phase 2
• Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 PneumoniaStatus unknownNCT04344730Not applicable
• Awake Prone Position for Early Hypoxemia in COVID-19CompletedNCT04344587Not applicable
• Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19Status unknownNCT04344457Phase 1/2
• Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe DiseaseTerminatedNCT04344444Phase 3
• Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19)Status unknownNCT04344431Phase 2/3
• Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the VirusCompletedNCT04344379Phase 3
• Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCFCompletedNCT04344327
• Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 InfectionTerminatedNCT04344288Phase 2
• Cohort of Patients With Inflammatory Bowel Disease During COVID-19 PandemicCompletedNCT04344249
• Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19WithdrawnNCT04344236Phase 2
• Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes MellitusCompletedNCT04344210Not applicable
• Surgery During Covid-19: The Role of Asymptomatic Patients, a SurveyCompletedNCT04344197
• CovidDB: The Covid-19 Inpatient DatabaseStatus unknownNCT04344171
• Exhaustion and Needs in Frontline COVID-19 Healthcare Workers: Cross-sectional Study in a Belgian PopulationCompletedNCT04344145
• Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19CompletedNCT04344080Not applicable
• COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial)CompletedNCT04344041Phase 3
• COVID-19 Plasma CollectionCompletedNCT04344015Not applicable
• LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID)CompletedNCT04344002

← COVID-19 overview